The Latest Regenerative Medicine Articles from Streetwise Reports

Three COVID-19 Patients Treated with PLX Cells

Research Report

Streetwise Reports (04/01/2020)

Three COVID-19 Patients Treated with PLX Cells

Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. read more >

'Stay Tuned for Data' from Regenerative Medicine Firm with 'Blockbuster Opportunity'

Research Report

Streetwise Reports (01/31/2020)

'Stay Tuned for Data' from Regenerative Medicine Firm with 'Blockbuster Opportunity'

The compelling aspects of this life sciences story are presented in a Dawson James report. read more >

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Streetwise Reports (12/11/2019)

Proteostasis Therapeutics' shares traded higher after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-2020, and potential for a Marketing Authorization Application in 2021. read more >

News Update

Regenerative Medicine Firm Advances Multifaceted Pipeline

News Update

Streetwise Reports (11/26/2019)

Regenerative Medicine Firm Advances Multifaceted Pipeline

The company continues advancing its cell therapies and medical device. read more >

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

Streetwise Reports (10/28/2019)

Shares of IVERIC bio traded 100% higher after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. read more >

Showing Results: 1 to 5 of 5